Nurix Therapeutics, Inc. NRIX Change in AP
Change in AP at other companies
Other financials
Where this comes from
Reported directly by Nurix Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsPayable.
The official record: Nurix Therapeutics, Inc.’s 10-Q, filed April 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Nurix Therapeutics, Inc.'s change in ap.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Nurix Therapeutics, Inc.'s change in AP?
- Nurix Therapeutics, Inc. (NRIX) reported change in AP of -$461K in Q4 2025.
- How has Nurix Therapeutics, Inc.'s change in AP changed year-over-year?
- Nurix Therapeutics, Inc.'s change in AP increased by 85.6% year-over-year, from -$3.21M to -$461K.
- What does change in AP mean?
- Increase or decrease in amounts owed to suppliers — a key working capital component affecting operating cash flow.